Evidence map›Paper›PMID 34551009›Full record

ArticlePloS one2021

Evaluation of a natural compound extracted from Dolichandrone atrovirens as a novel antioxidant agent using Caenorhabditis elegans.

Manoj Limbraj Yellurkar, Vibhavana Singh, Vani Sai Prasanna, Pamelika Das, Satheeshkumar Nanjappan, Ravichandiran Velayutham, Somasundaram Arumugam

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Xanthine oxidase inhibition study of isolated secondary metabolites fromSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  3. Icariin Improves Stress Resistance and Extends Lifespan inInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Manoj Limbraj YellurkarDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, (NIPER) Kolkata, Kolkata, West Bengal, India.ORCID 0000-0002-9627-6890
Vibhavana SinghDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, (NIPER) Kolkata, Kolkata, West Bengal, India.
Vani Sai PrasannaDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, (NIPER) Kolkata, Kolkata, West Bengal, India.
Pamelika DasDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, (NIPER) Kolkata, Kolkata, West Bengal, India.
Satheeshkumar NanjappanDepartment of Natural Products, National Institute of Pharmaceutical Education and Research, (NIPER) Kolkata, Kolkata, West Bengal, India.
Ravichandiran VelayuthamDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, (NIPER) Kolkata, Kolkata, West Bengal, India.
Somasundaram ArumugamDepartment of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, (NIPER) Kolkata, Kolkata, West Bengal, India.ORCID 0000-0002-2096-2552
National Institute of Pharmaceutical Education and Research · INNational Institute of Pharmaceutical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The compound methyl cinnamoyl catalpol (DAM-1) was isolated from the methanol extract of Dolichandrone atrovirens. Studies have already reported the antioxidant activity of Dolichandrone atrovirens bark extract, but till date the antioxidant activity of the isolated compound DAM-1, remains unexplored. The endogenous process of reactive oxygen species generation which leads to various degenerative diseases, can be broken down using these exogenous moieties from plant origin, herein this study we sought to evaluate the antioxidant potential of the DAM-1 compound using Caenorhabditis elegans (C. elegans), which is the primary model to study the antioxidant activity of compounds. Cytotoxicity assay results showed that DAM-1 treatment in the concentration of 10, 25 and 50 μg/ml has shown 100%, 91%, and 50% survival respectively with overall p<0.0001 (treatment v/s control group). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-Formazan (MTT) assay results showed that treatment had better survival rates than the control group at different time intervals i.e. 48 h, and 72 h with p<0.01. Mechanosensation (behavioral study) as well as in vivo study results showed that at 0 h, 10 μg/ml of DAM-1 treatment showed a better anti-oxidative activity than the control group, 25 and 50 μg/ml of DAM-1 treated groups with p<0.001 but at 2.5 h incubation with 10, 25, 50 μg/ml of DAM-1 showed an increased anti-oxidative activity than the control group with p<0.001. Thermoresistance assay confirmed that the treatment group had more survival than control group with p<0.001. Absorption study of DAM-1 in C. elegans has shown that the absorption of the drug increases up to 180 mins with a slight decrease after 360 mins and then constant absorption up to 1440 mins. This study paves the way towards the initiative to explore the pharmacological role of DAM-1 in various oxidative stress mediated diseases at molecular levels and the absorption study points out its potential role which could be utilized in the metabolomics and proteomics analysis of this compound in other studies.

Indexed as

AntioxidantsCaenorhabditis elegansPlant ExtractsAnimalsBiological ProductsIridoid GlucosidesOxidative StressReactive Oxygen SpeciesAntioxidantsBiological ProductsIridoid GlucosidesPlant ExtractsReactive Oxygen Species

Identifiers

PMID34551009
PMCPMC8457486
OpenAlexW3199344803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.